Related Experiment Videos
Prevalence and natural history of electrocardiographic left ventricular hypertrophy
Insights
Electrocardiographic left ventricular hypertrophy (ECG LVH) is a serious sign of cardiovascular disease, significantly increasing mortality risk. Its presence indicates underlying hypertension and potential myocardial damage, demanding prompt medical attention.
Area of Science:
- Cardiology
- Internal Medicine
- Diagnostic Electrocardiography
Background:
- Left ventricular hypertrophy (LVH) detected via electrocardiogram (ECG) is a significant indicator of cardiovascular disease and hypertension.
- Its prevalence increases with age and is slightly more common in males.
- ECG LVH is a serious prognostic sign, not merely an incidental finding.
Purpose of the Study:
- To investigate the prevalence, risk factors, and prognostic implications of electrocardiographic left ventricular hypertrophy (ECG LVH).
- To compare the prognostic value of ECG LVH with other indicators of cardiac enlargement.
- To understand the relationship between ECG LVH, hypertension, and cardiovascular outcomes.
Main Methods:
- Analysis of electrocardiographic data to identify left ventricular hypertrophy (LVH) using specific criteria.
- Correlation of ECG findings with patient demographics, blood pressure measurements, and clinical outcomes.
- Comparison of ECG LVH prevalence and risk with cardiac enlargement identified through roentgenograms.
Main Results:
- The prevalence of ECG LVH increases with age, affecting approximately 1 in 10 individuals aged 30-62 over 12 years.
- Cardiac enlargement on X-ray is twice as common as ECG LVH, but only 16% of those with X-ray evidence develop ECG LVH.
- Hypertension, especially systolic pressures >180 mm Hg, is a major predisposing factor for ECG LVH.
- ECG LVH is associated with an eightfold increase in cardiovascular mortality and a sixfold increase in coronary mortality.
- ECG LVH with repolarization abnormalities carries a higher risk than hypertension alone or cardiac enlargement, identifying patients with compromised coronary circulation and myocardial damage.
- Risk of stroke, cardiac failure, and coronary heart disease manifestations are substantially increased.
- ECG LVH solely based on voltage criteria reflects hypertension severity and carries half the cardiovascular risk of ECG LVH with repolarization abnormality.
Conclusions:
- Electrocardiographic left ventricular hypertrophy (ECG LVH) is a critical marker for increased cardiovascular morbidity and mortality.
- It signifies underlying hypertension, potential myocardial damage, and predicts a worse prognosis, including higher risks of stroke and heart failure.
- While the precise pathology is debated, ECG LVH, especially with repolarization abnormalities, is a grave prognostic sign in cardiovascular disease management.
Abstract:
Left ventricular hypertrophy, particularly on the electrocardiogram, is an ominous, not an incidental accompaniment of hypertension and cardiovascular disease. The prevalence of electrocardiographic left ventricular hypertrophy increases with age with a slight male predominance, and one in 10 persons aged 30 to 62 can expect to have it within 12 years. At any age, cardiac enlargement on roentgenograms is twice as prevalent as electrocardiographic left ventricular hypertrophy, and in only 16 percent of those with x-ray evidence of cardiac enlargement does electrocardiographic left ventricular hypertrophy subsequently develop. Hypertension predisposes and at systolic pressures exceeding 180 mm Hg evidence of electrocardiographic left ventricular hypertrophy develops in 50 percent, with no closer relation to diastolic, than to systolic pressure. In addition to drastic curtailment of life expectancy, electrocardiographic left ventricular hypertrophy is a harbinger of serious cardiovascular disease. Definite electrocardiographic left ventricular hypertrophy is associated with an eightfold increase in cardiovascular mortality and a sixfold increase in coronary mortality. Electrocardiographic left ventricular hypertrophy with repolarization criteria more than doubles the risk of hypertension alone and carries a greater risk of cardiovascular morbidity and mortality than cardiac enlargement. It identifies hypertensive patients with a compromised coronary circulation and myocardial damage. Risk of stroke, cardiac failure, and every clinical manifestation of coronary heart disease is substantially increased. In those with electrocardiographic left ventricular hypertrophy risk of cardiac failure is three times that in those with hypertension alone. Electrocardiographic left ventricular hypertrophy based solely on voltage criteria reflects chiefly the severity and duration of associated hypertension, carrying only half the cardiovascular risk of electrocardiographic left ventricular hypertrophy with repolarization abnormality. The precise pathologic and anatomic meaning of electrocardiographic left ventricular hypertrophy is unclear in view of the modest correlations with anatomic, x-ray, ventriculographic, and electrocardiographic measures of cardiac hypertrophy. The electrocardiographic aberrations are as much a product of myocardial damage as hypertrophy, and their appearance must be regarded as a grave prognostic sign in the course of cardiovascular disease.